PET/CT helps predict survival in patients with breast cancer

03/11/2012 | MolecularImaging.net

Changes in 18F-FDG PET/CT standard uptake value measured before and again three months after selective internal radiation therapy can help predict survival in patients who have hepatic metastases due to breast cancer, according to a study in the Journal of Nuclear Medicine. Patients who responded to radioembolization survived longer than those who didn't, the study found.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD